COVID-19 -- Worldwide/Unknown
New study by PHE shows for the first time that 2 doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant first identified in India.
From: Public Health England Published 22 May 2021
Vaccine effectiveness against symptomatic disease from the B.1.617.2 variant is similar after 2 doses compared to the B.1.1.7 (Kent) variant dominant in the UK, and we expect to see even higher levels of effectiveness against hospitalisation and death.
The study found that, for
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8379054&promed&0
No comments:
Post a Comment